CN Patent

CN100402031C — 含有瑞帕霉素羟基酯的胃肠外制剂

Assigned to Wyeth LLC · Expires 2008-07-16 · 18y expired

What this patent protects

本发明提供了3-羟基-2-(羟基甲基)-2-甲基丙酸的瑞帕霉素42-酯(CCI-779)的胃肠外制剂。

USPTO Abstract

本发明提供了3-羟基-2-(羟基甲基)-2-甲基丙酸的瑞帕霉素42-酯(CCI-779)的胃肠外制剂。

Drugs covered by this patent

Torisel (temsirolimus) · Pfizer

Patent Metadata

Patent number: CN100402031C
Jurisdiction: CN
Classification: —
Expires: 2008-07-16
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.